|
DPF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.382000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.846600E-04 |
| Normal-vs-Stage2 |
4.838200E-01 |
| Normal-vs-Stage3 |
8.964600E-01 |
| Normal-vs-Stage4 |
5.300200E-01 |
| Stage1-vs-Stage2 |
1.689550E-02 |
| Stage1-vs-Stage3 |
2.18060000001241E-06 |
| Stage1-vs-Stage4 |
1.537860E-03 |
| Stage2-vs-Stage3 |
3.739400E-01 |
| Stage2-vs-Stage4 |
8.442800E-01 |
| Stage3-vs-Stage4 |
4.058800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.807800E-02 |
| Normal-vs-AfricanAmerican |
4.847800E-01 |
| Normal-vs-Asian |
2.883900E-02 |
| Caucasian-vs-AfricanAmerican |
3.052800E-01 |
| Caucasian-vs-Asian |
2.090000E-01 |
| AfricanAmerican-vs-Asian |
1.590220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.386400E-02 |
| Normal-vs-Female |
1.314390E-02 |
| Male-vs-Female |
3.491000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.666200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.657800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.008800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.341800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.595600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.778580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.416200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.340500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.054800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.034000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.26679999998569E-06 |
| Normal-vs-Grade 2 |
3.044100E-04 |
| Normal-vs-Grade 3 |
3.144200E-01 |
| Normal-vs-Grade 4 |
8.203400E-01 |
| Grade 1-vs-Grade 2 |
1.492120E-02 |
| Grade 1-vs-Grade 3 |
2.27640000000084E-05 |
| Grade 1-vs-Grade 4 |
2.75890000001056E-06 |
| Grade 2-vs-Grade 3 |
3.583800E-04 |
| Grade 2-vs-Grade 4 |
9.58920000000418E-05 |
| Grade 3-vs-Grade 4 |
1.929800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.06530000002437E-07 |
| Normal-vs-ccB subtype |
7.698800E-01 |
| ccA subtype-vs-ccB subtype |
5.89449999921499E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.897900E-02 |
| Normal-vs-N1 |
9.652000E-01 |
| N0-vs-N1 |
3.133400E-01 |
|
|
